The Influence of Tetracyclines on T Cell Activation
Overview
Affiliations
Minocycline has been shown to have an anti-inflammatory effect in patients with rheumatoid arthritis (RA). Since there is evidence that RA is a T cell-mediated disease, we investigated the effect of minocycline on human T cell clones derived from the synovium of an RA patient. The T cells, when activated via the T cell receptor (TCR)/CD3 complex, were suppressed functionally by minocycline, resulting in a dose-dependent inhibition of T cell proliferation and reduction in production of IL-2, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha). Besides an inhibition of IL-2 production, minocycline exerted its effect on T cell proliferation by induction of a decreased IL-2 responsiveness. We showed that the chelating capacity of minocycline plays a crucial role in the inhibitory effect on T cell function, since the inhibitory effect on T cell proliferation could be annulled by addition of exogenous Ca2+. However, minocycline did not markedly influence the typical TCR/CD3-induced intracellular Ca2+ mobilization. Taken together, the results clearly indicate that minocycline has immunomodulating effects on human T cells.
Radic M, Belancic A, dogas H, Vuckovic M, Gelemanovic A, Faour A Antibiotics (Basel). 2025; 14(1).
PMID: 39858351 PMC: 11762017. DOI: 10.3390/antibiotics14010065.
Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway.
Tone M, Iwahori K, Hirata M, Ueyama A, Tani A, Haruta J J Immunother Cancer. 2024; 12(4).
PMID: 38621815 PMC: 11328671. DOI: 10.1136/jitc-2023-008334.
Host inflammatory response is the major factor in the progression of pneumonia.
Zhang Z, Wang P, Ma C, Wang J, Li W, Quan C Front Immunol. 2022; 13:929213.
PMID: 36119044 PMC: 9478202. DOI: 10.3389/fimmu.2022.929213.
Revisiting Minocycline in Intracerebral Hemorrhage: Mechanisms and Clinical Translation.
Zhang R, Yong V, Xue M Front Immunol. 2022; 13:844163.
PMID: 35401553 PMC: 8993500. DOI: 10.3389/fimmu.2022.844163.
Florou D, Mavropoulos A, Dardiotis E, Tsimourtou V, Siokas V, Aloizou A Front Immunol. 2021; 12:739186.
PMID: 34899697 PMC: 8662812. DOI: 10.3389/fimmu.2021.739186.